Search - tctmd.com

Displaying 701 - 720 of 777

Sort: Relevancy | Date

Presentation

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Presenter: Murray D. Esler

June 10, 2014

Presentation TVT 2014

Impact of Pulmonary Hypertension, RV Dysfunction, and/or Severe Tricuspid Regurgitation on Mitral Valve Therapies

Presenter: E. Murat Tuzcu

June 05, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

$Renal Denervation for Hypertension Refractory to Renal Artery Stenting$

Presentation

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

Presenter: Yvonne Bausback

May 02, 2014

Presentation

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Presenter: Gregg W. Stone

April 28, 2014

Presentation Fellows 2014

Renal Artery Intervention and Denervation for Resistant Hypertension

Presenter: Duane Pinto

April 14, 2014

Presentation

Prognostic Implications of Pulmonary Hypertension in Pts with Severe Aortic Stenosis Undergoing TAVR

Presenter: Adrien Lu?on

March 06, 2014

Presentation

Renal Denervation - Cardiosonic Update: The Hypertension Specialist’s Perspective

Presenter: Mel Lobo

December 01, 2013

Presentation

Beyond Hypertension - “Off-target” Effects of Renal Denervation in Hypertensive Patients

Presenter: Eli Lev

December 01, 2013

Presentation TCT 2013

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Presenter: Michael Jaff

October 31, 2013

Presentation TCT 2013

Noninvasive Evaluation and Treatment of Resistant Hypertension

Presenter: C. Venkata S. Ram

October 31, 2013

Presentation TCT 2013

Renal Denervation Beyond Hypertension: Status Update and Study Pathways for New Clinical Indications

Presenter: Felix Mahfoud

October 30, 2013

Presentation TCT 2013

Flash Lecture #3: Renal Denervation: Beyond Hypertension!

Presenter: Fabio Brito Jr.

October 30, 2013

Presentation TCT 2013

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Presenter: Krishna Rocha-Singh

October 30, 2013

Presentation TCT 2013

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

Presenter: Stefan Verheye

October 29, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Presenter: Shao-?Liang Chen

October 29, 2013

Presentation TCT 2013

Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients

Presenter: Yu Taniguchi

October 29, 2013

Presentation TCT 2013

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Presenter: Michael Davidson

October 28, 2013

Presentation TCT 2013

Radiofrequency Pulmonary Artery Denervation for Pulmonary Hypertension: Hemodynamic Results and Pathologic Insights from a Porcine Model

Presenter: Alex Rothman

October 28, 2013

Advertisement

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Impact of Pulmonary Hypertension, RV Dysfunction, and/or Severe Tricuspid Regurgitation on Mitral Valve Therapies

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Renal Artery Intervention and Denervation for Resistant Hypertension

Prognostic Implications of Pulmonary Hypertension in Pts with Severe Aortic Stenosis Undergoing TAVR

Renal Denervation - Cardiosonic Update: The Hypertension Specialist’s Perspective

Beyond Hypertension - “Off-target” Effects of Renal Denervation in Hypertensive Patients

Noninvasive Evaluation of Resistant Hypertension: Two Case Examples

Noninvasive Evaluation and Treatment of Resistant Hypertension

Renal Denervation Beyond Hypertension: Status Update and Study Pathways for New Clinical Indications

Flash Lecture #3: Renal Denervation: Beyond Hypertension!

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Pulmonary artery denervation to treat pulmonary arterial hypertension: a single-center, prospective, first-in-man PADN-1 study

Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Radiofrequency Pulmonary Artery Denervation for Pulmonary Hypertension: Hemodynamic Results and Pathologic Insights from a Porcine Model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content